Effectiveness of Wearable Digital Therapeutics in Improving Sleep Outcomes Among Individuals With Insomnia: Systematic Review and Meta-Analysis of Randomized Controlled Trials - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy of Wearable Digital Therapeutics in Enhancing Sleep Quality for Individuals with Insomnia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • By

  • Wenhui Zhu

  • Mingming Chen

  • Yixuan Guo

  • Bin Zhang

  • Chunliu Luo

  • September 11, 2026

Share

  • 1

    Insomnia affects 10% to 20% of adults, with higher prevalence in women and older populations.

  • 2

    Insomnia is linked to mental disorders, reduced quality of life, and significant economic burdens exceeding $100 billion annually in the U.S.

  • 3

    Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment, but access is limited due to therapist shortages and high costs.

  • 4

    Benzodiazepine receptor agonists provide temporary relief for insomnia but carry risks such as dependence and cognitive impairment.

  • 5

    Health care systems are prioritizing the identification of safe, effective, and scalable insomnia interventions due to its public health impact.

Original Source(s)

Related Content